Cocrystal Pharma, Inc. (NASDAQ:COCP) Short Interest Update

Cocrystal Pharma, Inc. (NASDAQ:COCP) saw a significant decrease in short interest in November. As of November 30th, there was short interest totalling 7,000 shares, a decrease of 12.5% from the November 15th total of 8,000 shares. Based on an average daily volume of 18,600 shares, the short-interest ratio is currently 0.4 days. Approximately 0.1% of the shares of the stock are short sold.

Cocrystal Pharma Stock Performance

NASDAQ:COCP traded down $0.05 on Tuesday, hitting $1.97. 6,160 shares of the stock were exchanged, compared to its average volume of 20,783. Cocrystal Pharma has a 52 week low of $1.33 and a 52 week high of $3.10. The stock has a market capitalization of $20.08 million, a price-to-earnings ratio of -1.09 and a beta of 1.52. The company’s 50-day moving average price is $1.94 and its 200 day moving average price is $2.02.

Analyst Ratings Changes

Separately, HC Wainwright lowered their price target on shares of Cocrystal Pharma from $10.00 to $7.00 and set a “buy” rating for the company in a report on Thursday, August 22nd.

About Cocrystal Pharma

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.